普米克令舒联合孟鲁司特对于毛细支气管炎的治疗效果

摘要

Objective:To observe the curative effect of Pulmicort Respules inhalation combined with oral montelukast in treatment of infant bronchiolitis.Method:80 infants with bronchiolitis were randomly divided into the experimental groupand the control group,with 40 cases in each group.The control group was given conventional therapy plus Xiyanping atomization combined with montelukast oral.The experimental group was given routine treatment Pulmicort Respules make comfortable atomization inhalation combined with montelukast oral.The main clinical symptoms and physical signs disappeared time and hospitalization time of the two groups after treatment were observed.Result:The total effective rate of experimental group(92.5%)was significantly higher than that in the control group(82.5%)(P<0.05). In the experimental group,the clinical symptoms and signs remission time and hospital stay were significantly shorter than the control group(P<0.05).Conclusion:Pulmicort Respules aerosol inhalation combined with oral montelukast for efficacy is better in the treatment of bronchiolitis,can relieve patients clinical signs and symptoms,shorten the hospitalization time,better safety,meaningful clinical promotion.%目的：观察普米克令舒雾化吸入联合孟鲁司特口服治疗婴幼儿毛细支气管炎的疗效。方法：将临床确诊为婴幼儿毛细支气管炎的80例患儿随机分成试验组、对照组各40例。对照组给予常规治疗加喜炎平雾化联合孟鲁司特口服，试验组给予常规治疗加普米克令舒雾化吸入联合孟鲁司特口服。观察两组治疗后的主要临床症状和体征消失时间及住院时间。结果：试验组总有效率（92.5%）明显高于对照组总有效率（82.5%），两组比较差异有统计学意义（P<0.05）。试验组患儿各临床症状和体征缓解时间及住院时间均明显短于对照组，比较差异有统计学意义（P<0.05）。结论：普米克令舒雾化吸入联合孟鲁司特口服对于治疗毛细支气管炎的疗效较好，能明显缓解患者临床体征和症状，明显缩短住院时间，安全性更好，有临床推广意义。